Cathie Wood 10x Genomics, Inc. Transaction History

Ark Investment Management LLC

$11.4 Billion
Q4 2024

A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Ark Investment Management LLC holds 11,944,057 shares of TXG stock, worth $144 Million. This represents 1.5% of its overall portfolio holdings.

Number of Shares

11,944,057

Previous 10,750,345 11.1%

Holding current value

$144 Million

Previous $243 Million 29.34%

% of portfolio

1.5%

Previous 2.31%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	BUY	$13.18 - $21.31 $15.7 Million - $25.4 Million	1,193,712 Added 11.1%	11,944,057 $172 Million
Q3 2024 Oct 31, 2024	BUY	$15.71 - $23.49 $22.6 Million - $33.7 Million	1,436,582 Added 15.42%	10,750,345 $243 Million
Q2 2024 Jul 26, 2024	BUY	$19.45 - $37.37 $58.9 Million - $113 Million	3,029,951 Added 48.22%	9,313,763 $181 Million
Q1 2024 Apr 18, 2024	BUY	$36.08 - $54.3 $80.9 Million - $122 Million	2,242,525 Added 55.49%	6,283,812 $236 Million
Q4 2023 Jan 17, 2024	BUY	$34.32 - $57.55 $36 Million - $60.3 Million	1,047,827 Added 35.0%	4,041,287 $226 Million
Q3 2023 Oct 18, 2023	SELL	$40.86 - $62.98 $4.91 Million - $7.56 Million	-120,089 Reduced 3.86%	2,993,460 $123 Million
Q2 2023 Jul 10, 2023	SELL	$50.96 - $58.72 $53.1 Million - $61.2 Million	-1,041,774 Reduced 25.07%	3,113,549 $174 Million
Q1 2023 Apr 17, 2023	SELL	$35.33 - $55.79 $5.7 Million - $9 Million	-161,244 Reduced 3.74%	4,155,323 $232 Million
Q4 2022 Jan 24, 2023	SELL	$24.4 - $41.3 $6.35 Million - $10.7 Million	-260,247 Reduced 5.69%	4,316,567 $0
Q3 2022 Oct 17, 2022	BUY	$28.48 - $52.59 $27.7 Million - $51.2 Million	973,528 Added 27.02%	4,576,814 $130 Million
Q2 2022 Jul 11, 2022	BUY	$36.95 - $82.41 $7.83 Million - $17.5 Million	211,948 Added 6.25%	3,603,286 $184 Million
Q1 2022 Apr 19, 2022	BUY	$55.7 - $145.79 $40.7 Million - $106 Million	730,472 Added 27.45%	3,391,338 $258 Million
Q4 2021 Jan 28, 2022	SELL	$135.05 - $182.59 $59.6 Million - $80.5 Million	-441,085 Reduced 14.22%	2,660,866 $396 Million
Q3 2021 Nov 12, 2021	SELL	$145.58 - $192.14 $174 Million - $230 Million	-1,198,086 Reduced 27.86%	3,101,951 $452 Million
Q2 2021 Aug 05, 2021	BUY	$134.22 - $202.37 $107 Million - $161 Million	795,916 Added 22.71%	4,300,037 $842 Million
Q1 2021 May 13, 2021	BUY	$140.25 - $196.86 $417 Million - $585 Million	2,970,625 Added 556.82%	3,504,121 $634 Million
Q4 2020 Feb 12, 2021	BUY	$126.47 - $163.7 $38.2 Million - $49.5 Million	302,399 Added 130.85%	533,496 $75.5 Million
Q3 2020 Oct 30, 2020	SELL	$87.44 - $125.0 $9.22 Million - $13.2 Million	-105,456 Reduced 31.33%	231,097 $28.8 Million
Q2 2020 Aug 11, 2020	BUY	$58.39 - $89.31 $19.7 Million - $30.1 Million	336,553 New	336,553 $30.1 Million

Others Institutions Holding TXG

# of Institutions

293

Shares Held

97.3M

Call Options Held

263K

Put Options Held

85.1K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.15B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track Cathie Wood's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.

Account